Seahorse Bioscience Announces 2012 XF Users’ Meeting in Asia

Billerica, MA, January 2, 2012 – Seahorse Bioscience, the leader in cellular bioenergetics instrumentation, has announced that its 2012 XF Users’ Meeting, to be held February 28th – March 1st, 2012 will be held in Tokyo, Japan, and co-hosted by Seahorse’s Japan distributor, Primetech.

The meeting will offer Seahorse Extracellular Flux (XF) Analyzer users a great opportunity to learn about the latest developments in XF technology, and network with other XF experts and users. Interactive workshops will facilitate discussions regarding cellular bioenergetics research, and the role of mitochondrial dysfunction, and its impact on many diseases. Keynote speakers will include distinguished academic and business leaders from throughout Asia. Agenda topics planned include: profiling mitochondrial function with the XF Mito Stress Test, understanding and measuring glycolytic function, advanced data analysis and interpretation, and more.

"Seahorse hosts regular XF user events, with previous meetings held in Nice, France, in 2011, and Annapolis, Maryland, in 2010. By listening to our customers Seahorse ensures that its leading-edge XF technology is focused on real-world, cellular bioenergetics research needs, said Steve Chomicz, Vice President of Sales & Marketing."

The XF Analyzer measures cellular bioenergetics, simultaneously measuring the two major energy-producing pathways of the cell - mitochondrial respiration and glycolysis - in a micro plate, in real-time. The XF Analyzer and Stress Test Kits are the gold standard for measuring mitochondrial dysfunction and glycolysis, enabling scientists to better understand the connection of physiological traits of cells with genomic and proteomic data. This knowledge is generating new insights into mitochondrial dysfunction, leading to a greater understanding, and new treatments of diseases as the human lifespan increases.

About Seahorse Bioscience

Seahorse XF instruments have become the new standard in cellular bioenergetic measurements. Over 1,500 scientists worldwide are advancing their research in understanding the role of cellular bioenergetics in Neurodegeneration, Aging, Cancer, Cardiovascular, Cell Physiology, Toxicology & Hepatobiology, Immunology, Infectious Diseases, Mitochondrial Diseases, Model Organisms, Obesity, Diabetes, Metabolic Disorders, Screening, and Translational Medicine. Founded in 2001, Seahorse Bioscience is headquartered in Billerica, Massachusetts, U.S., and has regional offices in Copenhagen, Denmark; and Shanghai, China.